Charles Rosier (Page Charles Rosier : Crunchbase.com) was offered a great job at Goldman Sachs (GMS) in 1999. When he accepted the offer, he became their Managing Director. Having more than 30 years of experience in working with international markets, BTG Pactual currently hires 2,500 workers. He was liable for the French-speaking markets of France, Belgium, as well as Quebec at UBS Warburg. Charles Rosier’s appointment at Lehman Brothers in 1996 was his first step towards his future. Eventually, he became the manager of their Debt Capital Market Division, having transferred to UBS Warburg in 1997.
Charles Rosier was the project’s major investor. A drug treatment for strokes that can cause spinal cord damage was being tested. Professor Etienne Baulieu led Mapreg, a pharmacological firm that was supported by Mr Rosier when he began his healthcare projects. The Mapreg Drug project was Charles Rosier’s first healthcare project.
Projects that Promote Culture
Charles Rosier has a passion for culture and music. This is obvious from the type of support he gives for movies and singers. Charles Rosier likes music and singing. Movies are also one of his passions. That is why he supports French culture. His support for a famous French female performer was a fantastic example of his passion for culture and music.
How Charles Rosier Was Educated
In 1991, Charles Rosier attended his secondary education at Paris’s Fenelon Sainte-Marie. Whilst pursuing his career, he occupied many different positions, which transformed him into experienced banker. Charles Rosier earned his first scientific Baccalaureate degree (which is similar to A-levels in the UK).
Charles Rosier’s Professional Experiences
GMS (Goldman Sachs) is a leading investment bank that operates around the globe. In his role as their Managing Director, he paid much attention to public asset management. Charles Rosier was an ambitious partner of an investment bank in Latin America called BTG Pactual. Charles Rosier became the Managing Director of Goldman Sachs, which is a huge investment banking institution, from 2009 to 2010.